MPS Pharmaa Stock Price Analysis and Quick Research Report. Is MPS Pharmaa an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse MPS Pharmaa. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). MPS Pharmaa has a PE ratio of -4.05290102389078 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. MPS Pharmaa has ROA of -8.2602% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. MPS Pharmaa has a Current ratio of 0.2741.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. MPS Pharmaa has a ROE of -34.9177%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. MPS Pharmaa has a Debt to Equity ratio of 3.6947 which means that the company has high proportion of debt in its capital.

• Sales growth: MPS Pharmaa has reported revenue growth of 0% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of MPS Pharmaa for the current financial year is 0%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for MPS Pharmaa is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of MPS Pharmaa is Rs -0.4688. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of MPS Pharmaa in Ticker for free. Also, one can get the intrinsic value of MPS Pharmaa by using Valuation Calculators, which are available with a Finology ONE subscription. 

MPS Pharmaa FAQs

Q1. What is MPS Pharmaa share price today?
Ans: The current share price of MPS Pharmaa is Rs 1.9.

Q2. What is the market capitalisation of MPS Pharmaa?
Ans: MPS Pharmaa has a market capitalisation of Rs 3.631166 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of MPS Pharmaa?
Ans: The PE ratio of MPS Pharmaa is -4.05290102389078 and the P/B ratio of MPS Pharmaa is 4.27350427350427, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of MPS Pharmaa share?
Ans: The 52-week high share price of MPS Pharmaa is Rs 4.33, and the 52-week low share price of MPS Pharmaa is Rs 1.9.

Q5. Does MPS Pharmaa pay dividends?
Ans: Currently, MPS Pharmaa does not pay dividends. Dividend yield of MPS Pharmaa is around 0%.

Q6. What are the face value and book value of MPS Pharmaa shares?
Ans: The face value of MPS Pharmaa shares is Rs 10, while the book value per share of MPS Pharmaa is around Rs 0.4446. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of MPS Pharmaa?
Ans: MPS Pharmaa has a total debt of Rs 7.2741245 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of MPS Pharmaa?
Ans: The ROE of MPS Pharmaa is -34.9177% and ROCE of MPS Pharmaa is -9.0583%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is MPS Pharmaa a good buy for the long term?
Ans: The MPS Pharmaa long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is MPS Pharmaa undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the MPS Pharmaa appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check MPS Pharmaa’s financials?
Ans: You can review MPS Pharmaa’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.